ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

HVO Hvivo Plc

28.75
0.25 (0.88%)
Last Updated: 08:00:05
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hvivo Plc LSE:HVO London Ordinary Share GB00B9275X97 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.25 0.88% 28.75 28.50 29.00 28.75 28.75 28.75 365,308 08:00:05
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 48.48M -776k -0.0011 -261.36 194.08M

hVIVO plc Share Incentive Plan and PDMR Dealings (0122O)

24/01/2019 10:12am

UK Regulatory


Hvivo (LSE:HVO)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Hvivo Charts.

TIDMHVO

RNS Number : 0122O

hVIVO plc

24 January 2019

HVIVO PLC

("hVIVO" or the "Company")

Share Incentive Plan and PDMR Dealings

London, UK, 24 January 2019: hVIVO plc (AIM: HVO), an industry leading clinical development services business pioneering human disease models based upon viral and allergen challenge, announces that as part of the Company's commitment to encouraging all employees to be shareholders in the business, a total of 1,689,258 Ordinary Shares of 5 pence each (the "New Ordinary Shares") have been granted to employees pursuant to a new employee share incentive plan introduced by hVIVO on 21 January 2019 (the "Share Incentive Plan").

A total of 138 employees were found eligible and applied for the Share Incentive Plan and have been granted 12,241 free Ordinary Shares each representing approximately GBP3,600 at the purchase price. The free shares were awarded on 21 January 2019 and are subject to a 3 year forfeiture period.

Application has been made to AIM for the admission of the New Ordinary Shares ("Admission"), which will rank pari passu in all respects with the Company's existing shares in issue, and Admission is expected to occur on 25 January 2019.

Following Admission, the total number of ordinary shares with voting rights in issue will be 82,296,965 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

Dr Trevor Phillips (Executive Chairman), Tim Sharpington (COO, PDMR) and Shelley Fraser (Finance Director, PDMR) have been allotted 12,241 shares each, see below for further details.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail:

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1    Details of the persons discharging managerial responsibilities/persons 
       closely associated 
 a)   Name                   Trevor Phillips 
     ---------------------  -------------------------------------------------- 
 2    Reason for the notification 
     ------------------------------------------------------------------------- 
 a)   Position/              Executive Chairman 
       status 
     ---------------------  -------------------------------------------------- 
 b)   Initial                Initial Notification 
       notification/ 
       Amendment 
     ---------------------  -------------------------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ------------------------------------------------------------------------- 
 a)   Name                   hVIVO plc 
     ---------------------  -------------------------------------------------- 
 b)   Legal Entity           N/A 
       Identifier 
     ---------------------  -------------------------------------------------- 
 4    Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place where 
       transactions have been conducted 
     ------------------------------------------------------------------------- 
 a)   Description            Ordinary shares of 5 pence each 
       of the financial 
       instrument, 
       type of                GB00B6ZM0X53 
       instrument 
       Identification 
       code 
     ---------------------  -------------------------------------------------- 
 b)   Nature of              Award of ordinary shares pursuant to Share 
       the transaction        Incentive Plan 
     ---------------------  -------------------------------------------------- 
 c)   Currency               GBP 
     ---------------------  -------------------------------------------------- 
 d)   Price(s)                     Director           Price (p)   Volume 
       and volume(s)                Trevor Phillips    29.41p      12,241 
                                                      ----------  ------- 
     --------------------- 
 
 e)   Aggregated 
       information 
       - Aggregated 
        volume 
       - Price                12,241 
       - Aggregated            29.41p 
        total 
                               GBP3,600 
     ---------------------  -------------------------------------------------- 
 f)   Date of                21 January 2019 
       the transaction 
     ---------------------  -------------------------------------------------- 
 g)   Place of               London Stock Exchange, AIM 
       the transaction 
     ---------------------  -------------------------------------------------- 
 
 
 1    Details of the persons discharging managerial responsibilities/persons 
       closely associated 
 a)   Name                   Tim Sharpington 
     ---------------------  -------------------------------------------------- 
 2    Reason for the notification 
     ------------------------------------------------------------------------- 
 a)   Position/              COO, PDMR 
       status 
     ---------------------  -------------------------------------------------- 
 b)   Initial                Initial Notification 
       notification/ 
       Amendment 
     ---------------------  -------------------------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ------------------------------------------------------------------------- 
 a)   Name                   hVIVO plc 
     ---------------------  -------------------------------------------------- 
 b)   Legal Entity           N/A 
       Identifier 
     ---------------------  -------------------------------------------------- 
 4    Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place where 
       transactions have been conducted 
     ------------------------------------------------------------------------- 
 a)   Description            Ordinary shares of 5 pence each 
       of the financial 
       instrument, 
       type of                GB00B6ZM0X53 
       instrument 
       Identification 
       code 
     ---------------------  -------------------------------------------------- 
 b)   Nature of              Award of ordinary shares pursuant to Share 
       the transaction        Incentive Plan 
     ---------------------  -------------------------------------------------- 
 c)   Currency               GBP 
     ---------------------  -------------------------------------------------- 
 d)   Price(s)                     Director           Price (p)   Volume 
       and volume(s)                Tim Sharpington    29.41p      12,241 
                                                      ----------  ------- 
     --------------------- 
 
 e)   Aggregated 
       information 
       - Aggregated 
        volume 
       - Price                12,241 
       - Aggregated            29.41p 
        total 
                               GBP3,600 
     ---------------------  -------------------------------------------------- 
 f)   Date of                21 January 2019 
       the transaction 
     ---------------------  -------------------------------------------------- 
 g)   Place of               London Stock Exchange, AIM 
       the transaction 
     ---------------------  -------------------------------------------------- 
 
 
 1    Details of the persons discharging managerial responsibilities/persons 
       closely associated 
 a)   Name                   Shelley Fraser 
     ---------------------  -------------------------------------------------- 
 2    Reason for the notification 
     ------------------------------------------------------------------------- 
 a)   Position/              Finance Director, PDMR 
       status 
     ---------------------  -------------------------------------------------- 
 b)   Initial                Initial Notification 
       notification/ 
       Amendment 
     ---------------------  -------------------------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ------------------------------------------------------------------------- 
 a)   Name                   hVIVO plc 
     ---------------------  -------------------------------------------------- 
 b)   Legal Entity           N/A 
       Identifier 
     ---------------------  -------------------------------------------------- 
 4    Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place where 
       transactions have been conducted 
     ------------------------------------------------------------------------- 
 a)   Description            Ordinary shares of 5 pence each 
       of the financial 
       instrument, 
       type of                GB00B6ZM0X53 
       instrument 
       Identification 
       code 
     ---------------------  -------------------------------------------------- 
 b)   Nature of              Award of ordinary shares pursuant to Share 
       the transaction        Incentive Plan 
     ---------------------  -------------------------------------------------- 
 c)   Currency               GBP 
     ---------------------  -------------------------------------------------- 
 d)   Price(s)                      Director          Price (p)   Volume 
       and volume(s)                Shelley Fraser    29.41p      12,241 
                                                     ----------  ------- 
     --------------------- 
 
 e)   Aggregated 
       information 
       - Aggregated 
        volume 
       - Price                12,241 
       - Aggregated            29.41p 
        total 
                               GBP3,600 
     ---------------------  -------------------------------------------------- 
 f)   Date of                21 January 2019 
       the transaction 
     ---------------------  -------------------------------------------------- 
 g)   Place of               London Stock Exchange, AIM 
       the transaction 
     ---------------------  -------------------------------------------------- 
 

For further information please contact:

 
 hVIVO plc 
 Trevor Phillips (Executive Chairman)       +44 207 756 1300 
 Fleur Wood (EVP, Investor Relations 
  & Communications) 
 Numis Securities Limited                    +44 207 260 1000 
 Michael Meade / Freddie Barnfield 
  (Nominated Adviser) 
 James Black / Michael Burke (Corporate 
  Broking) 
 
 FTI Consulting 
 Simon Conway / Victoria Foster Mitchell    +44 203 727 1000 
 

Notes to Editors:

hVIVO plc ("hVIVO") is pioneering a human-based analytical platform to accelerate drug discovery and development in respiratory and infectious diseases. Leveraging human disease models in flu, RSV and asthma exacerbation, the hVIVO platform captures disease in motion, illuminating the entire disease life cycle from healthy to sick and back to health. Based in the UK, market leader hVIVO has conducted more than 50 clinical studies, inoculated over 2500 volunteers and has three first-in-class therapies currently in development.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHPGUMUGUPBGUC

(END) Dow Jones Newswires

January 24, 2019 05:12 ET (10:12 GMT)

1 Year Hvivo Chart

1 Year Hvivo Chart

1 Month Hvivo Chart

1 Month Hvivo Chart

Your Recent History

Delayed Upgrade Clock